Decline in subarachnoid haemorrhage volumes associated with the first wave of the COVID-19 pandemic.

Decline in subarachnoid haemorrhage volumes associated with the first wave of the COVID-19 pandemic.
复制标题

DOI:
10.1136/svn-2020-000695
复制
发表时间:
2021-12
影响因子:
5.9
通讯作者:
Japanese Society of Vascular and Interventional Neurology Society (JVIN)
Japanese Society of Vascular and Interventional Neurology Society (JVIN)
中科院分区:
医学1区
文献类型:
--
作者:
Nguyen TN;Haussen DC;Qureshi MM;Yamagami H;Fujinaka T;Mansour OY;Abdalkader M;Frankel M;Qiu Z;Taylor A;Lylyk P;Eker OF;Mechtouff L;Piotin M;Lima FO;Mont'Alverne F;Izzath W;Sakai N;Mohammaden M;Al-Bayati AR;Renieri L;Mangiafico S;Ozretic D;Chalumeau V;Ahmad S;Rashid U;Hussain SI;John S;Griffin E;Thornton J;Fiorot JA;Rivera R;Hammami N;Cervantes-Arslanian AM;Dasenbrock HH;Vu HL;Nguyen VQ;Hetts S;Bourcier R;Guile R;Walker M;Sharma M;Frei D;Jabbour P;Herial N;Al-Mufti F;Ozdemir AO;Aykac O;Gandhi D;Chugh C;Matouk C;Lavoie P;Edgell R;Beer-Furlan A;Chen M;Killer-Oberpfalzer M;Pereira VM;Nicholson P;Huded V;Ohara N;Watanabe D;Shin DH;Magalhaes PS;Kikano R;Ortega-Gutierrez S;Farooqui M;Abou-Hamden A;Amano T;Yamamoto R;Weeks A;Cora EA;Sivan-Hoffmann R;Crosa R;Möhlenbruch M;Nagel S;Al-Jehani H;Sheth SA;Lopez Rivera VS;Siegler JE;Sani AF;Puri AS;Kuhn AL;Bernava G;Machi P;Abud DG;Pontes-Neto OM;Wakhloo AK;Voetsch B;Raz E;Yaghi S;Mehta BP;Kimura N;Murakami M;Lee JS;Hong JM;Fahed R;Walker G;Hagashi E;Cordina SM;Roh HG;Wong K;Arenillas JF;Martinez-Galdamez M;Blasco J;Rodriguez Vasquez A;Fonseca L;Silva ML;Wu TY;John S;Brehm A;Psychogios M;Mack WJ;Tenser M;Todaka T;Fujimura M;Novakovic R;Deguchi J;Sugiura Y;Tokimura H;Khatri R;Kelly M;Peeling L;Murayama Y;Winters HS;Wong J;Teleb M;Payne J;Fukuda H;Miyake K;Shimbo J;Sugimura Y;Uno M;Takenobu Y;Matsumaru Y;Yamada S;Kono R;Kanamaru T;Morimoto M;Iida J;Saini V;Yavagal D;Bushnaq S;Huang W;Linfante I;Kirmani J;Liebeskind DS;Szeder V;Shah R;Devlin TG;Birnbaum L;Luo J;Churojana A;Masoud HE;Lopez CY;Steinfort B;Ma A;Hassan AE;Al Hashmi A;McDermott M;Mokin M;Chebl A;Kargiotis O;Tsivgoulis G;Morris JG;Eskey CJ;Thon J;Rebello L;Altschul D;Cornett O;Singh V;Pandian J;Kulkarni A;Lavados PM;Olavarria VV;Todo K;Yamamoto Y;Silva GS;Geyik S;Johann J;Multani S;Kaliaev A;Sonoda K;Hashimoto H;Alhazzani A;Chung DY;Mayer SA;Fifi JT;Hill MD;Zhang H;Yuan Z;Shang X;Castonguay AC;Gupta R;Jovin TG;Raymond J;Zaidat OO;Nogueira RG;SVIN COVID-19 Registry, the Middle East North Africa Stroke and Interventional Neurotherapies Organization (MENA-SINO);Japanese Society of Vascular and Interventional Neurology Society (JVIN)

文献摘要

参考文献

被引文献

相似文献

在COVID-19大流行期间,报告的中风入院和机械血栓切除术数量减少。该研究的目的是检查蛛网膜下腔出血(SAH)住院和破裂动脉瘤弹簧圈栓塞术是否表现出类似的下降。我们在6大洲、37个国家和140个综合性卒中中心进行了一项横断面、回顾性、观察性研究。通过前瞻性动脉瘤数据库或国际疾病分类第10次修订版代码确定诊断为SAH、蛛网膜下腔出血、破裂动脉瘤弹簧圈栓塞术和COVID-19的患者。比较了大流行之前(1年和之前不久)和大流行期间(定义为2020年3月1日至5月31日)的3个月累积量、SAH住院和破裂动脉瘤弹簧圈栓塞术的月量。获得之前1年的控制期(2019年3月1日至5月31日),以解释季节性变化。蛛网膜下腔出血住院率显著下降,大流行前3个月有2044例住院,大流行期间有1585例住院,相对下降22.5%(95%CI-24.3%至-20.7%,p<0.0001)。破裂动脉瘤的栓塞分别在1170-1035例手术中下降,相对下降11.5%(95%CI-13.5%至-9.8%,p=0.002)。亚组分析显示,蛛网膜下腔出血住院从834例下降至626例,相对下降24.9%(95%CI-28.0%至-22.1%,p<0.0001)。在弹簧圈栓塞治疗量低的医院中,破裂动脉瘤弹簧圈栓塞治疗的相对增加为41.1%(95% CI 32.3%至50.6%,p=0.008),尽管该三分位数中SAH入院率降低。在COVID-19大流行期间,SAH住院、蛛网膜下腔出血住院和破裂动脉瘤栓塞的数量相对减少。SAH中的这些发现与其他紧急情况(如中风和心肌梗死)的减少一致。
During the COVID-19 pandemic, decreased volumes of stroke admissions and mechanical thrombectomy were reported. The study’s objective was to examine whether subarachnoid haemorrhage (SAH) hospitalisations and ruptured aneurysm coiling interventions demonstrated similar declines. We conducted a cross-sectional, retrospective, observational study across 6 continents, 37 countries and 140 comprehensive stroke centres. Patients with the diagnosis of SAH, aneurysmal SAH, ruptured aneurysm coiling interventions and COVID-19 were identified by prospective aneurysm databases or by International Classification of Diseases, 10th Revision, codes. The 3-month cumulative volume, monthly volumes for SAH hospitalisations and ruptured aneurysm coiling procedures were compared for the period before (1 year and immediately before) and during the pandemic, defined as 1 March–31 May 2020. The prior 1-year control period (1 March–31 May 2019) was obtained to account for seasonal variation. There was a significant decline in SAH hospitalisations, with 2044 admissions in the 3 months immediately before and 1585 admissions during the pandemic, representing a relative decline of 22.5% (95% CI −24.3% to −20.7%, p<0.0001). Embolisation of ruptured aneurysms declined with 1170–1035 procedures, respectively, representing an 11.5% (95%CI −13.5% to −9.8%, p=0.002) relative drop. Subgroup analysis was noted for aneurysmal SAH hospitalisation decline from 834 to 626 hospitalisations, a 24.9% relative decline (95% CI −28.0% to −22.1%, p<0.0001). A relative increase in ruptured aneurysm coiling was noted in low coiling volume hospitals of 41.1% (95% CI 32.3% to 50.6%, p=0.008) despite a decrease in SAH admissions in this tertile. There was a relative decrease in the volume of SAH hospitalisations, aneurysmal SAH hospitalisations and ruptured aneurysm embolisations during the COVID-19 pandemic. These findings in SAH are consistent with a decrease in other emergencies, such as stroke and myocardial infarction.
DOI: 10.1177/1747493021991652
发表时间: 2021-07
期刊: International journal of stroke : official journal of the International Stroke Society
影响因子: --
作者:
Nogueira RG;Abdalkader M;Qureshi MM;Frankel MR;Mansour OY;Yamagami H;Qiu Z;Farhoudi M;Siegler JE;Yaghi S;Raz E;Sakai N;Ohara N;Piotin M;Mechtouff L;Eker O;Chalumeau V;Kleinig TJ;Pop R;Liu J;Winters HS;Shang X;Vasquez AR;Blasco J;Arenillas JF;Martinez-Galdamez M;Brehm A;Psychogios MN;Lylyk P;Haussen DC;Al-Bayati AR;Mohammaden MH;Fonseca L;Luís Silva M;Montalverne F;Renieri L;Mangiafico S;Fischer U;Gralla J;Frei D;Chugh C;Mehta BP;Nagel S;Mohlenbruch M;Ortega-Gutierrez S;Farooqui M;Hassan AE;Taylor A;Lapergue B;Consoli A;Campbell BC;Sharma M;Walker M;Van Horn N;Fiehler J;Nguyen HT;Nguyen QT;Watanabe D;Zhang H;Le HV;Nguyen VQ;Shah R;Devlin T;Khandelwal P;Linfante I;Izzath W;Lavados PM;Olavarría VV;Sampaio Silva G;de Carvalho Sousa AV;Kirmani J;Bendszus M;Amano T;Yamamoto R;Doijiri R;Tokuda N;Yamada T;Terasaki T;Yazawa Y;Morris JG;Griffin E;Thornton J;Lavoie P;Matouk C;Hill MD;Demchuk AM;Killer-Oberpfalzer M;Nahab F;Altschul D;Ramos-Pachón A;Pérez de la Ossa N;Kikano R;Boisseau W;Walker G;Cordina SM;Puri A;Luisa Kuhn A;Gandhi D;Ramakrishnan P;Novakovic-White R;Chebl A;Kargiotis O;Czap A;Zha A;Masoud HE;Lopez C;Ozretic D;Al-Mufti F;Zie W;Duan Z;Yuan Z;Huang W;Hao Y;Luo J;Kalousek V;Bourcier R;Guile R;Hetts S;Al-Jehani HM;AlHazzani A;Sadeghi-Hokmabadi E;Teleb M;Payne J;Lee JS;Hong JM;Sohn SI;Hwang YH;Shin DH;Roh HG;Edgell R;Khatri R;Smith A;Malik A;Liebeskind D;Herial N;Jabbour P;Magalhaes P;Ozdemir AO;Aykac O;Uwatoko T;Dembo T;Shimizu H;Sugiura Y;Miyashita F;Fukuda H;Miyake K;Shimbo J;Sugimura Y;Beer-Furlan A;Joshi K;Catanese L;Abud DG;Neto OG;Mehrpour M;Al Hashmi A;Saqqur M;Mostafa A;Fifi JT;Hussain S;John S;Gupta R;Sivan-Hoffmann R;Reznik A;Sani AF;Geyik S;Akıl E;Churojana A;Ghoreishi A;Saadatnia M;Sharifipour E;Ma A;Faulder K;Wu T;Leung L;Malek A;Voetsch B;Wakhloo A;Rivera R;Barrientos Iman DM;Pikula A;Lioutas VA;Thomalla G;Birnbaum L;Machi P;Bernava G;McDermott M;Kleindorfer D;Wong K;Patterson MS;Fiorot JA Jr;Huded V;Mack W;Tenser M;Eskey C;Multani S;Kelly M;Janardhan V;Cornett O;Singh V;Murayama Y;Mokin M;Yang P;Zhang X;Yin C;Han H;Peng Y;Chen W;Crosa R;Frudit ME;Pandian JD;Kulkarni A;Yagita Y;Takenobu Y;Matsumaru Y;Yamada S;Kono R;Kanamaru T;Yamazaki H;Sakaguchi M;Todo K;Yamamoto N;Sonoda K;Yoshida T;Hashimoto H;Nakahara I;Cora E;Volders D;Ducroux C;Shoamanesh A;Ospel J;Kaliaev A;Ahmed S;Rashid U;Rebello LC;Pereira VM;Fahed R;Chen M;Sheth SA;Palaiodimou L;Tsivgoulis G;Chandra R;Koyfman F;Leung T;Khosravani H;Dharmadhikari S;Frisullo G;Calabresi P;Tsiskaridze A;Lobjanidze N;Grigoryan M;Czlonkowska A;de Sousa DA;Demeestere J;Liang C;Sangha N;Lutsep HL;Ayo-Martín Ó;Cruz-Culebras A;Tran AD;Young CY;Cordonnier C;Caparros F;De Lecinana MA;Fuentes B;Yavagal D;Jovin T;Spelle L;Moret J;Khatri P;Zaidat O;Raymond J;Martins S;Nguyen T
通讯作者: Nguyen T
DOI: 10.1016/j.clineuro.2020.106436
发表时间: 2021-03
影响因子: 1.9
作者:
Ortega-Gutierrez S;Farooqui M;Zha A;Czap A;Sebaugh J;Desai S;Jadhav A;Vora N;Rai V;Jovin TG;Thon JM;Heslin M;Thau L;Zevallos C;Quispe-Orozco D;Jillella DV;Nahab F;Mohammaden MH;Nogueira RG;Haussen DC;Nguyen TN;Romero JR;Aparicio HJ;Osman M;Haq IU;Liebeskind D;Hassan AE;Zaidat O;Siegler JE;SVIN COVID-19 Multinational Registry and Task Force
通讯作者: SVIN COVID-19 Multinational Registry and Task Force
DOI: 10.1161/strokeaha.120.030373
发表时间: 2020-07-01
期刊: STROKE
影响因子: 8.3
作者:
Kerleroux, Basile;Fabacher, Thibaut;Boulouis, Gregoire
通讯作者: Boulouis, Gregoire
DOI: 10.1159/000345247
发表时间: 2013-01-01
期刊: NEUROEPIDEMIOLOGY
影响因子: 5.7
作者:
Ishihara, Hideyuki;Kunitsugu, Ichiro;Suzuki, Michiyasu
通讯作者: Suzuki, Michiyasu
DOI: 10.1007/s00701-020-04437-z
发表时间: 2020-06-08
影响因子: 2.4
作者:
Hecht, Nils;Wessels, Lars;Vajkoczy, Peter
通讯作者: Vajkoczy, Peter